Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
PHIO: Phio Pharmaceuticals Corp. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
PHIO
The Story
PHIO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-67.1%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
66.93×
Phio Pharmaceuticals Corp.
PHIO
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Phio Pharmaceuticals Corp.
PHIO
NASDAQ
·
USD
·
Closed
$1.02
−0.49%
$1.02
−$0.01 (0.49%)
52W Range
6th
pctl
Volume
0.15×
avg
Mkt Cap
11.91M
USD
P/E
-0.7
TTM
Div Yield
–
ann
52W Range
6th
pctl
Volume
0.15×
avg
Market Cap
11.91M
USD
P/E Ratio
-0.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings